Sosei Heptares Operational Highlights and Consolidated
Tokyo, Japan and Cambridge, UK, 12 May 2023 – Sosei Group Corporation (“the Company”; TSE: 4565) provides an update on operational activities and reports...
Source: globenewswire.com
Page 8 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sosei Group Today - Breaking & Trending Today
Sosei : Consolidated Financial Results for the Three Months Ended March 31, 2023 (IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2023 ... | May 12, 2023
Source: marketscreener.com
Neurocrine Biosciences Reports First Quarter 2023 Financial Results
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2023 and provided an...
Source: prnewswire.com
Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Prime Market
08.03.2023 - Tokyo, Japan and Cambridge, UK, 8 March 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design (SBDD) and development, is pleased to announce it has ...
Source: wallstreet-online.de
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides Financial Expectations for 2023
/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the fourth quarter and fiscal year ended December 31,...
Source: prnewswire.com